Too-funny. She has a tell. When she jumps in, sh

Too-funny. She has a tell. When she jumps in, she promotes their evaluation model, which is very solid in my opinion. When she is out, she promotes the 100M financing needed, which is way off, by 50M. The third cycle now, hopefully people on ihub see through the charade by now. She loses credibility by doing that. Pick a side. Watch for rollingwiththefda to show up soon, he only shows up in the 'out' times.

Quote:

---

as in trial enrollment failure at best?

---